{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T12:13:32Z","timestamp":1715948012937},"reference-count":0,"publisher":"Editorial Office of Chinese Journal of Cancer","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chin J Cancer"],"published-print":{"date-parts":[[2013,5,5]]},"DOI":"10.5732\/cjc.011.10432","type":"journal-article","created":{"date-parts":[[2011,12,16]],"date-time":"2011-12-16T02:17:53Z","timestamp":1324001873000},"page":"1-4","source":"Crossref","is-referenced-by-count":1,"title":["Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?"],"prefix":"10.5732","volume":"32","author":[{"given":"Guo-Yan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3724","container-title":["Chinese Journal of Cancer"],"original-title":[],"deposited":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T08:42:29Z","timestamp":1367570549000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cjcsysu.cn\/abstract.asp?fr=doi&idno=20069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,5]]},"references-count":0,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.5732\/cjc.011.10432","relation":{},"ISSN":["1000-467X","1944-446X"],"issn-type":[{"value":"1000-467X","type":"print"},{"value":"1944-446X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,5]]}}}